A systematic review assessing the under-representation of elderly adults in COVID-19 trials

Virginie Prendki(Hôpital Beau-Séjour), Dafna Yahav(Sheba Medical Center), Marco Falcone, Laurent Kaiser(University Hospital of Geneva), Yaara Leibovici-Weissmann(Tel Aviv University), Angela Huttner(University Hospital of Geneva), Mical Paul(Technion – Israel Institute of Technology), Tomer Avni(Tel Aviv University), Noam Tau(Sheba Medical Center)

Research Square

October 29, 2020

10.21203/rs.3.rs-39538/v2

Cited by 1

Related Papers

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

|Clinical Microbiology and Infection|2021|1k

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

|JAMA|2018|779

Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

|Antimicrobial Agents and Chemotherapy|2010|727

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

|The Lancet Infectious Diseases|2017|521

β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

|BMJ|2004|467